BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15625841)

  • 21. [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation].
    Ran HH; Pan KL; Zhang R; Wang YF
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):408-12. PubMed ID: 17052403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.
    Hale GA; Bowman LC; Woodard JP; Cunningham JM; Benaim E; Horwitz EM; Heslop HE; Krance RA; Leung W; Shearer PD; Handgretinger R
    Bone Marrow Transplant; 2003 Jun; 31(11):981-6. PubMed ID: 12774048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation.
    Ishikawa J; Maeda T; Kashiwagi H; Yoshida H; Takahashi I; Kawamoto SI; Yamada M; Kato H; Nishiura T; Tomiyama Y; Matsuzawa Y
    Bone Marrow Transplant; 2003 Jun; 31(11):1057-9. PubMed ID: 12774060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on graft-versus-leukemia effects of donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation].
    Du B; Li D; Xu K
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):403-7. PubMed ID: 11718089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful autologous bone marrow transplantation in second remission of malignant histiocytosis.
    Cazin B; Gorin NC; Jouet JP; Laporte JP; Fenaux P; Walter MP; Najman A; Gosselin B; Bauters F
    Bone Marrow Transplant; 1990 Jun; 5(6):431-3. PubMed ID: 1695116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of clinical outcome between allogeneic peripheral blood stem cell transplantation and bone marrow transplantation].
    Wang M; Han M; Feng S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):427-30. PubMed ID: 11721425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X.
    Ringdén O; Ahström L; Lönnqvist B; Båryd I; Svedmyr E; Gahrton G
    N Engl J Med; 1987 Mar; 316(12):733-5. PubMed ID: 3547128
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful bone marrow transplantation for idiopathic hypereosinophilic syndrome.
    Fukushima T; Kuriyama K; Ito H; Miyazaki Y; Arimura K; Hata T; Saitoh M; Tomonaga M
    Br J Haematol; 1995 May; 90(1):213-5. PubMed ID: 7786788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification?
    Laurencet FM; Chapuis B; Roux-Lombard P; Dayer JM; Beris P
    Leukemia; 1994 Mar; 8(3):502-6. PubMed ID: 8127155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X.
    Dehner LP
    N Engl J Med; 1987 Sep; 317(12):773-4. PubMed ID: 3306383
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of hospital procedure volume with post-transplant survival for allogeneic bone marrow transplantation.
    Park CS; Moon HK; Kang HY; Min YH; Cho WH
    J Prev Med Public Health; 2004 Feb; 37(1):26-36. PubMed ID: 25363030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant histiocytosis and immunodeficiency].
    Liu KF
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):89-91. PubMed ID: 2582556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
    Ruan GJ; Zanwar S; Ravindran A; Schram S; Abeykoon JP; Hazim A; Young JR; Shah MV; Bennani NN; Jiang L; Morlote D; Rech KL; Goyal G; Go RS;
    Am J Hematol; 2024 May; 99(5):871-879. PubMed ID: 38409747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.